Pennsylvania Nets $4 Million in Avandia Settlement
Pennsylvania will rake in more than $4 million as part of a national settlement with GlaxoSmithKline over unlawful promotion of the diabetes drug Avandia.
The total payout – which will be shared by 37 states – is $90 million.
The settlement follows a flood of accusations that the British-based pharmaceutical company dangerously downplayed Avandia’s cardiovascular risks and side effects.
For more than 40 years, the Pennsylvania injury lawyers at Munley Law Personal Injury Attorneys have helped people who have been harmed as a result of unfair and deceptive business practices.
As part of the consent agreement, GlaxoSmithKline will change how it markets and promotes Avandia by:
- Not making bogus claims about Avandia;
- Not making safety claims about Avandia that are unsupported by substantial evidence or clinical experience;
- Not promoting investigational drugs; and
- Not misusing statistics or otherwise misrepresenting the nature, applicability, or significance of clinical trials regarding Avandia.
Free Consultation With a Scranton Avandia Injury Attorney
Have you or someone you know been injured after taking Avandia? Suffered a loss as the result of some other defective or dangerous product? Talk with an experienced Pennsylvania drug injury lawyer at Munley Law Personal Injury Attorneys. We help people and families in Pennsylvania whose lives have been disrupted by an accident, injury or harmful product. Call 877-763-2343 or use this contact form.
Share this post: